Publications by authors named "Drew Velting"

Claim this Profile
C
Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease.
Richard S Isaacson, Steven Ferris, Drew M Velting, Xiangyi Meng

Am J Alzheimers Dis Other Demen· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease.
Martin R Farlow, George T Grossberg, Carl H Sadowsky, Xiangyi Meng, Drew M Velting

Alzheimer Dis Assoc Disord· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease.
Joseph L Micca, James E Galvin, Drew M Velting, Xiangyi Meng

SAGE Open Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor.
George T Grossberg, Martin R Farlow, Xiangyi Meng, Drew M Velting

Curr Alzheimer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease.
Martin R Farlow, Carl H Sadowsky, Drew M Velting, Xiangyi Meng, M Zahur Islam

CNS Neurosci Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical algorithm for managing Alzheimer's disease: what, when, and why?
Jeffrey L Cummings, Richard S Isaacson, Frederick A Schmitt, Drew M Velting

Ann Clin Transl Neurol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.
Carl H Sadowsky, Joseph L Micca, George T Grossberg, Drew M Velting

Prim Care Companion CNS Disord· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERP correlates of form and rhyme letter tasks in impaired reading children: a critical evaluation.
Deborah Lovrich, Jeff Cheng, Drew Velting

Child Neuropsychol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis